These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8540732)

  • 41. Interaction between theophylline and enoxacin.
    Takagi K; Hasegawa T; Yamaki K; Suzuki R; Watanabe T; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):288-92. PubMed ID: 3165968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinant of the distribution volume at steady state for novel quinolone pazufloxacin in rats.
    Hayakawa H; Takagi K; Takano YF; Kawamura Y; Tsuji A
    J Pharm Pharmacol; 2002 Sep; 54(9):1229-36. PubMed ID: 12356277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers.
    Davy M; Allen A; Bird N; Rost KL; Fuder H
    Chemotherapy; 1999; 45(6):478-84. PubMed ID: 10567778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Absorption, distribution, metabolism and excretion of T-3761, a new quinolone derivative, in experimental animals].
    Minami S; Takahata M; Hayashi T; Kumano K; Ikeda Y; Noumi T; Takagi S; Oogake N; Tsuneda R; Maehana J
    Jpn J Antibiot; 1995 May; 48(5):626-42. PubMed ID: 7637197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of pharmacokinetic interaction between moxifloxacin, a novel 8-methoxyfluoroquinolone, and theophylline.
    Stass H; Kubitza D
    Clin Pharmacokinet; 2001; 40 Suppl 1():63-70. PubMed ID: 11352444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.
    Girard D; Gootz TD; McGuirk PR
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1671-6. PubMed ID: 1329625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.
    Gregoire SL; Grasela TH; Freer JP; Tack KJ; Schentag JJ
    Antimicrob Agents Chemother; 1987 Mar; 31(3):375-8. PubMed ID: 3472488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of fluoroquinolone antimicrobials alone and in conjunction with theophylline on seizures in amygdaloid kindled rats. Mechanistic and pharmacokinetic study.
    Vancutsem PM; Schwark WS
    Epilepsy Res; 1992 Oct; 13(1):59-71. PubMed ID: 1335867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of effect of aciclovir on metabolism of theophylline and expression of hepatic cytochrome P450 1A2 in rats.
    Nadai M; Kato M; Yasui K; Kimura M; Zhao YL; Ueyama J; Tsunekawa Y; Yoshizumi H; Hasegawa T
    Biol Pharm Bull; 2007 Mar; 30(3):562-8. PubMed ID: 17329857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline.
    Baskaran R; Shanmugam S; Nagayya-Sriraman S; Kim JH; Jeong TC; Yong CS; Choi HG; Yoo BK
    Arch Pharm Res; 2008 Jul; 31(7):938-44. PubMed ID: 18704339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative effects of ciprofloxacin and lomefloxacin on the oxidative metabolism of theophylline.
    Robson RA; Begg EJ; Atkinson HC; Saunders DA; Frampton CM
    Br J Clin Pharmacol; 1990 Apr; 29(4):491-3. PubMed ID: 2328197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug interactions with clinafloxacin.
    Randinitis EJ; Alvey CW; Koup JR; Rausch G; Abel R; Bron NJ; Hounslow NJ; Vassos AB; Sedman AJ
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2543-52. PubMed ID: 11502527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic interaction between theophylline and chloramphenicol in rats.
    Busby M; Lesko LJ
    Drug Metab Dispos; 1987; 15(2):204-6. PubMed ID: 2882979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of probenecid and ranitidine on urinary excretion of lomefloxacin in rats.
    Sasaki M; Fujimura A
    Jpn J Pharmacol; 1996 Jul; 71(3):263-4. PubMed ID: 8854210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of atropine on pharmacokinetics of theophylline in rabbits.
    Li JH; Yang SM; Deng ZH
    Drug Metabol Drug Interact; 1991; 9(2):115-22. PubMed ID: 1800018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
    Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of hepatic regeneration after partial hepatectomy on theophylline pharmacokinetics in rats.
    Maza AM; Gascon AR; Hernandez RM; Solinis MA; Calvo MB; Pedraz JL
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):53-8. PubMed ID: 11554434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.